Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acutemyocardial infarction: In Vitro and in Vivo investigation

Journal of Tissue Engineering

Volumn 2, Issue 1, 2011, Pages 1-7

  Nayan, Madhur ^a   Paul, Arghya ^b   Chen, Guangyong ^a   Chiu, Ray C J ^a   Prakash, Satya ^b   Shum Tim, Dominique ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; DEPOSITION; ECHOCARDIOGRAPHY; FLOWCHARTING; STEM CELLS; SURGERY;

BONE MARROW MESENCHYMAL; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS; EJECTION FRACTION; IN-VITRO; MARROW MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; THERAPEUTIC POTENTIALS; VITRO AND IN VIVO;

CELL CULTURE;

EID: 84890219472     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.4061/2011/741213     Document Type: Article

References (29)

1. W. Dai, S. L. Hale, B. J. Martin et al., "Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects," Circulation, vol. 112, no. 2, pp. 214-223, 2005.
2. J. M. Hare, J. H. Traverse, T. D. Henry et al., "A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction," Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277-2286, 2009.
3. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999.
4. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder, "Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms," American Journal of Physiology, vol. 289, no. 1, pp. F31-F42, 2005.
5. P. Niemeyer, J. Vohrer, H. Schmal et al., "Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice," Cytotherapy, vol. 10, no. 8, pp. 784-795, 2008.
6. G. Chen, M. Nayan, M. Duong et al., "Marrow stromal cells for cell-based therapy: the role of antiinflammatory cytokines in cellular cardiomyoplasty," Annals of Thoracic Surgery, vol. 90, no. 1, pp. 190-197, 2010.
7. R. Atoui, J. F. Asenjo, M. Duong, G. Chen, R. C. Chiu, and D. Shum-Tim, "Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance," Annals of Thoracic Surgery, vol. 85, no. 2, pp. 571-579, 2008.
8. D. Egrise, D. Martin, A. Vienne, P. Neve, and A. Schoutens, "The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats," Bone, vol. 13, no. 5, pp. 355-361, 1992.
9. R. Quarto, D. Thomas, and C. T. Liang, "Bone progenitor cell deficits and the age-associated decline in bone repair capacity," Calcified Tissue International, vol. 56, no. 2, pp. 123-129, 1995.
10. A. Stolzing and A. Scutt, "Age-related impairment of mesenchymal progenitor cell function," Aging Cell, vol. 5, no. 3, pp. 213-224, 2006.
11. S. V. Tokalov, S. Grüner, S. Schindler, A. S. Iagunov, M. Baumann, and N. D. Abolmaali, "A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats," Molecules and Cells, vol. 24, no. 2, pp. 255-260, 2007.
12. H. Zheng, J. A. Martin, Y. Duwayri, G. Falcon, and J. A. Buckwalter, "Impact of aging on rat bonemarrow-derived stemcell chondrogenesis," Journals of Gerontology, vol. 62, no. 2, pp. 136-148, 2007.
13. C. Nakanishi, M. Yamagishi, K. Yamahara et al., "Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells," Biochemical and Biophysical Research Communications, vol. 374, no. 1, pp. 11-16, 2008.
14. J. Rehman, D. Traktuev, J. Li et al., "Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells," Circulation, vol. 109, no. 10, pp. 1292-1298, 2004.
15. A. Paul, Y. Ge, S. Prakash, and D. Shum-Tim, "Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy," Regenerative Medicine, vol. 4, no. 5, pp. 733-745, 2009.
16. A. Paul, D. Shum-Tim, and S. Prakash, "Investigation on PEG integrated alginate-chitosan microcapsules for myocardial therapy using marrow stem cells genetically modified by recombinant baculovirus," Cardiovascular Engineering and Technology, vol. 1, pp. 154-164, 2010.
17. S. Davani, A. Marandin, N. Mersin et al., "Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model," Circulation, vol. 108, pp. II- 253-II-258, 2003.
18. A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, "Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies," Mechanisms of Ageing and Development, vol. 129, no. 3, pp. 163-173, 2008.
19. J. M. Edelberg, L. Tang, K. Hattori, D. Lyden, and S. Rafii, "Young adult bonemarrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function," Circulation Research, vol. 90, no. 10, pp. E89-E93, 2002.
20. M. Hirayama, E. Azuma, Q. Jiang et al., "The reconstitution of CD45RBhiCD4+ naive T cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation," British Journal of Haematology, vol. 111, no. 2, pp. 700-707, 2000.
21. F. M. Rauscher, P. J. Goldschmidt-Clermont, B. H. Davis et al., "Aging, progenitor cell exhaustion, and atherosclerosis," Circulation, vol. 108, no. 4, pp. 457-463, 2003.
22. H. Zhang, S. Fazel, H. Tian et al., "Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy," American Journal of Physiology, vol. 289, no. 5, pp. H2089-H2096, 2005.
23. M. Gnecchi, H. He, N. Noiseux et al., "Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement," Federation of American Societies for Experimental Biology Journal, vol. 20, no. 6, pp. 661-669, 2006.
24. T. Kilic, D. Ural, E. Ural et al., "Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome," Heart, vol. 92, no. 8, pp. 1041-1046, 2006.
25. E. J. Molina, J. Palma, D. Gupta et al., "Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stemcell (MSC) treatment of pressure overload hypertrophy," Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 2, pp. 85-91, 2009.
26. T. A. Markel, P. R. Crisostomo, M. C. Manukyan et al., "Are neonatal stem cells as effective as adult stem cells in providing ischemic protection?" Journal of Surgical Research, vol. 152, no. 2, pp. 325-330, 2009.
27. R. M. Takeuchi, L. Takeuchi, M. Hurtado et al., "Age associated responsiveness to allogeneic mesenchymal stem cell (MSC) transplantation after ischemia-reperfusion (IR) in rats," Circulation, vol. 120, p. S876, 2009.
28. C. D. Kan, S. H. Li, R. D. Weisel, S. Zhang, and R. K. Li, "Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation," Journal of the American College of Cardiology, vol. 50, no. 11, pp. 1086-1092, 2007.
29. R. Quinn, "Comparing rat's to human's age: how old is my rat in people years?" Nutrition, vol. 21, no. 6, pp. 775-777, 2005.